In a Nov. 5 report, Haywood Capital Markets analyst Neal Gilmer maintained his “Buy” rating and C$15.00 target price on Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL), citing steady execution, resilient profitability, and a solid outlook heading into fiscal 2026. Trulieve reported third-quarter revenue of US$288.2-million, up 1.4% year over year […]
Saskatoon-based MustGrow Biologics (MustGrow Biologics Stock Quote, Chart, News, Analysts, Financials TSXV:MGRO) is bringing biotechnology and regenerative agriculture together to help farmers replace synthetic chemicals and fertilizers, CEO Corey Giasson said in an Oct. 31 interview on the Cantech Letter YouTube channel. Speaking with Ticker Take host Jon Erlichman at the 2025 Cantech Investment Conference […]
Share
Tweet
Share
